Physician profile
Timothy G Saxe
NPI 1174520282
$8,707.87
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,539 · 2020: $2,447 · 2021: $2,512 · 2022: $1,211.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,071.33 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $764.62 | 2019-2022 | |
| Novo Nordisk INC | $690.13 | 2019-2022 | |
| Glaxosmithkline, LLC. | $679.79 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $653.47 | 2019-2022 | |
| Amarin Pharma, INC. | $561.25 | 2019-2022 | |
| Abbvie INC. | $506.58 | 2021-2022 | |
| Allergan, INC. | $478.33 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $444.53 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $416.35 | 2019-2021 | |
| Amgen INC. | $403.25 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $347.47 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $263.21 | 2019-2020 | |
| Lilly USA, LLC | $226.95 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $193.11 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $158.75 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $149.45 | 2019 | |
| Valeritas, INC. | $138.57 | 2019 | |
| Indivior INC. | $85.28 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.77 | 2022 | |
| Daiichi Sankyo INC. | $63.28 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $59.59 | 2021 | |
| Novartis Pharmaceuticals Corporation | $57.00 | 2020-2022 | |
| Eisai INC. | $41.38 | 2020 | |
| Mallinckrodt Enterprises LLC | $29.46 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.83 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.18 | 2021 | |
| Nevro Corp. | $18.21 | 2021 | |
| Shionogi INC | $15.80 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.53 | 2021 | |
| Astellas Pharma US INC | $15.34 | 2022 | |
| Jazz Pharmaceuticals INC. | $13.67 | 2020 | |
| Shire North American Group INC | $13.11 | 2019 | |
| Mdd US Operations, LLC | $11.30 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Saxe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.